Management of Excessive Salivation (Hypersalivation)
For patients with excessive salivation (hypersalivation), anticholinergic medications are recommended as first-line pharmacological therapy, with glycopyrrolate being the preferred initial medication due to its established efficacy and safety profile. 1, 2
First-Line Treatment Options
Non-Pharmacological Approaches (for mild cases)
- Sugar-free acidic candies or lozenges
- Sugar-free chewing gum
- Mechanical stimulants that promote swallowing
- Postural adjustments to improve oral control
First-Line Pharmacological Treatment
Glycopyrrolate (oral solution)
- Mechanism: Competitive inhibitor of acetylcholine receptors on salivary glands 2
- Dosing: Start at 0.02 mg/kg three times daily, titrate up in increments of 0.02 mg/kg every 5-7 days 2
- Maximum dose: 0.1 mg/kg three times daily, not exceeding 1.5-3 mg per dose based on weight 2
- Administration: At least one hour before or two hours after meals (high-fat meals reduce bioavailability by ~74%) 2
- Advantages: Less likely to cross blood-brain barrier, resulting in fewer central nervous system side effects 2
Scopolamine (transdermal patch)
- Applied behind the ear every 72 hours
- Useful for patients who have difficulty with oral medications
Second-Line Treatment Options
Botulinum Toxin Injections
- Recommended for patients with inadequate response or intolerance to anticholinergic therapy 1
- Injected into salivary glands (parotid and submandibular)
- Effects last several months, requiring repeat injections
- Safe and effective with long-lasting saliva reduction 3
Other Anticholinergic Medications
- Atropine (sublingual drops)
- Benztropine
- Trihexyphenidyl
Treatment Algorithm Based on Severity
Mild Hypersalivation
- Start with non-pharmacological interventions
- If ineffective, consider low-dose glycopyrrolate
Moderate Hypersalivation
- Glycopyrrolate oral solution (first-line)
- Alternative: Scopolamine transdermal patch
- Adjust dosage based on response and side effects
Severe Hypersalivation
Special Considerations
Clozapine-Induced Hypersalivation
- Particularly common side effect with clozapine therapy
- Consider adding amisulpride as it has been reported effective 5
- Alpha-2-adrenergic agonists like clonidine may also be beneficial 5
Neuromuscular Disorders
- For patients with neuromuscular weakness and hypersalivation, anticholinergic medications should be tried first 1
- If ineffective, consider botulinum toxin therapy 1
- Address underlying swallowing dysfunction and aspiration risk
Monitoring and Side Effects
Common Side Effects of Anticholinergics
- Dry mouth, constipation, urinary retention
- Blurred vision, flushing, nasal congestion
- Cognitive impairment (more common with agents that cross blood-brain barrier)
Contraindications
- Glaucoma
- Paralytic ileus
- Unstable cardiovascular status
- Severe ulcerative colitis
- Myasthenia gravis 2
Precautions
- Monitor for constipation, particularly within 4-5 days of initial dosing or after dose increases 2
- Use with caution in patients with renal impairment as glycopyrrolate is largely renally eliminated 2
- Avoid high ambient temperatures to reduce risk of heat prostration 2
Treatment Approach for Specific Conditions
Sjögren's Syndrome
- For mild oral dryness: Non-pharmacological stimulation with sugar-free acidic candies or lozenges 1
- For moderate glandular dysfunction: Consider muscarinic agonists like pilocarpine 1
- For severe cases with no salivary output: Saliva substitution 1
Parkinson's Disease and Neurological Conditions
- Anticholinergic medications are effective but may worsen cognitive function
- Consider botulinum toxin as an alternative with fewer systemic side effects 4, 3
By following this systematic approach to managing hypersalivation, clinicians can effectively control symptoms while minimizing adverse effects, ultimately improving patient quality of life.